Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· HRH.R. 9679 (117th)referred
United States · United States Congress · 22 December 2022
Medical Cannabis Research Act of 2022 This bill establishes a new, separate registration process for manufacturers of cannabis for research. As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers. The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.
Bill· HRH.R. 9687 (117th)referred
United States · United States Congress · 22 December 2022
Medical Innovation Act of 2022 This bill requires certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a relevant settlement agreement regarding specified violations must pay 0.75%-1.5% of its net income to the Department of Health and Human Services for each of its covered blockbuster drugs. A covered blockbuster drug is a drug that has at least $1 billion in net sales in a year and was developed, in whole or in part, through federal investments in medical research. Payments are divided between the FDA and the NIH in proportion to the discretionary funding of those agencies, excluding FDA user fees. Payments are not disbursed if appropriations for the FDA or the NIH are lower than in the prior fiscal year. Priorities for payments must include advancing regulatory science for medical products and research related to diseases that disproportionately account for federal health care spending. A covered blockbuster drug for which a manufacturer has not made a required payment is considered misbranded and subject to prohibitions on introducing or receiving misbranded drugs in interstate commerce.
Bill· HRH.R. 9676 (117th)referred
United States · United States Congress · 22 December 2022
Rare disease Advancement, surveillance Research, and Education Act of 2022 or the RARE Act of 2022 The bill reauthorizes through FY2028 the National Institutes of Health Rare Disease Regional Centers of Excellence and expands activities to facilitate research and increase awareness of rare diseases and conditions. (Rare diseases and conditions are those with a prevalence of fewer than 200,000 individuals in the United States.) The Centers for Disease Control and Prevention may expand infrastructure and activities to track the epidemiology of up to four rare diseases and conditions and incorporate this information into a National Rare Disease or Condition Surveillance System. The Agency for Healthcare Research and Quality must expand its activities to increase health care providers' awareness of rare diseases and conditions. The National Academies of Sciences, Engineering, and Medicine, or another appropriate entity, must update the 2010 report Rare Diseases and Orphan Products: Accelerating Research and Development.
Bill· SS. 5354 (117th)referred
United States · United States Congress · 22 December 2022
One Health Security Act This bill establishes an interagency policy council that is focused on matters pertaining to One Health and national security. One Health refers to a multisectoral and transdisciplinary approach for achieving optimal health outcomes for people, domestic and wild animals, plants, and their shared environments and ecosystems. Specifically, the council must advise the President about, develop a strategy for, and generally coordinate federal activities related to One Health Security (i.e., the operational and functional security of the United States against naturally occurring, accidental, and deliberate biological threats, including identified threats, criminal acts, terrorist acts, supply chain failure and system failure, cyberattacks, or other relevant threats affecting One Health and national security).
Bill· HRH.R. 9644 (117th)referred
United States · United States Congress · 21 December 2022
National All-Payer Claims Database Act of 2022 This bill establishes a national all-payer claims database to collect and publish health care claims and payment information from various insurers.
Bill· HRH.R. 9658 (117th)referred
United States · United States Congress · 21 December 2022
Securing Access to Care for Seniors in Critical Condition Act of 2022 This bill exempts discharges from long-term care hospitals from the Medicare site-neutral payment rate if the discharge meets specified high acuity criteria and occurs on or after October 1, 2025.
Bill· HRH.R. 9657 (117th)referred
United States · United States Congress · 21 December 2022
Protecting Life from Chemical Abortions Act This bill prohibits certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. The bill prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
Bill· HRH.R. 9655 (117th)referred
United States · United States Congress · 21 December 2022
Medicare for America Act of 2019 [ sic ] This bill establishes several health insurance programs and otherwise modifies certain requirements relating to health care coverage, costs, and services. In particular, the bill establishes a national health insurance program to be administered by the Department of Health and Human Services (HHS). Among other requirements, the program must (1) cover all U.S. residents; (2) cover specified items and services, including hospital services, prescription drugs, dental services, and home- and community-based long-term care; and (3) be fully implemented in 2026. HHS must also offer a transitional public health option that provides certain minimum coverage through health insurance exchanges in 2024 and 2025. The bill also makes a series of other changes to health care and tax provisions. For example, the bill (1) allows federal funds to be used for abortions; (2) sunsets a specified tax reform law that, among other things, repealed the penalty for failing to maintain minimum essential health coverage; and (3) prohibits excessive prices for prescription drugs and medical devices, as determined by a newly established federal regulatory board.
Bill· SS. 5348 (117th)referred
United States · United States Congress · 21 December 2022
Protecting Veteran Community Care Act This bill modifies the community care program for veterans, including to expand access to community mental health care providers.
Bill· SS. 5336 (117th)referred
United States · United States Congress · 21 December 2022
PREEMIE Reauthorization Act of 2022 This bill reauthorizes through FY2028 research, health care provider education, and other activities focused on preventing and treating preterm birth.
Bill· HRH.R. 9634 (117th)referred
United States · United States Congress · 20 December 2022
Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
Bill· HRH.R. 9638 (117th)referred
United States · United States Congress · 20 December 2022
Medicare Payment Reform for People with ALS Act of 2022 This bill provides for specific Medicare coverage and payment of services for individuals with amyotrophic lateral sclerosis (ALS).
Bill· SS. 5303 (117th)referred
United States · United States Congress · 20 December 2022
Health Marketplace for All Act of 2022 This bill permits entities such as self-employed companies and membership organizations to form health marketplace pools to offer large group health insurance plans as a single employer. (In general, large group health plans cover employees of an employer that has 51 or more employees; in some states, large groups are defined as 101 employees or more.) Subject to specified nondiscrimination rules related to preexisting conditions and health status, health marketplace pools must offer plans to all members or employees of the pool on an equal basis. Health marketplace pools are not considered joint employers for the purpose of other federal labor or employment laws.
Bill· SS. 5310 (117th)referred
United States · United States Congress · 20 December 2022
Helping Kids Through Trauma Act This bill expressly permits state-licensed mental health organizations that receive grants for preservice or in-service training in a behavioral health-related paraprofessional field to use the grants for training on meeting the needs of children and adolescents who have experienced trauma.
Bill· SS. 5316 (117th)referred
United States · United States Congress · 20 December 2022
Federal Clarity for Kratom Consumers Act This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
Bill· SS. 5327 (117th)referred
United States · United States Congress · 20 December 2022
National Task Force on the COVID-19 Pandemic Act This bill establishes a legislative branch task force to investigate the facts and circumstances of the COVID-19 pandemic, including preparedness for and responses to the pandemic.
Resolution· SRESS.Res. 875 (117th)referred
United States · United States Congress · 20 December 2022
This resolution declares racism a public health crisis and commits to efforts to address health disparities and inequities.
Bill· SS. 5325 (117th)referred
United States · United States Congress · 20 December 2022
Behavioral Intervention Guidelines Act of 2022 This bill requires the Substance Abuse and Mental Health Services Administration to report on best practices for behavioral and mental health intervention teams that support students who exhibit behaviors interfering with learning or who are at risk of harm to self or others in elementary schools, secondary schools, and institutions of higher education.
Bill· SS. 5322 (117th)referred
United States · United States Congress · 20 December 2022
Medical Innovation Act of 2022 This bill requires certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a relevant settlement agreement regarding specified violations must pay 0.75%-1.5% of its net income to the Department of Health and Human Services for each of its covered blockbuster drugs. A covered blockbuster drug is a drug that has at least $1 billion in net sales in a year and was developed, in whole or in part, through federal investments in medical research. Payments are divided between the FDA and the NIH in proportion to the discretionary funding of those agencies, excluding FDA user fees. Payments are not disbursed if appropriations for the FDA or the NIH are lower than in the prior fiscal year. Priorities for payments must include advancing regulatory science for medical products and research related to diseases that disproportionately account for federal health care spending. A covered blockbuster drug for which a manufacturer has not made a required payment is considered misbranded and subject to prohibitions on introducing or receiving misbranded drugs in interstate commerce.
Bill· SS. 5314 (117th)referred
United States · United States Congress · 20 December 2022
Lost Opportunities to Supply Transplantable Organs Act of 2022 or the LOST Organs Act of 2022 This bill requires the Organ Procurement and Transplantation Network to take specified actions related to the transportation of organs, including tracking and publicly reporting the status of organs in the transplant supply chain. The Organ Procurement and Transplantation Network is a public-private partnership that links the professionals involved in the U.S. donation and transplantation system.
Bill· SS. 5304 (117th)referred
United States · United States Congress · 20 December 2022
Protect Our Services Today Act of 2022 or the POST Act This bill prohibits the U.S. Postal Service (USPS) from closing any USPS facility during the COVID-19 public health emergency period.
Bill· SS. 5293 (117th)referred
United States · United States Congress · 19 December 2022
Health Enterprise Zones Act of 2022 This bill provides for the designation of Health Enterprise Zones in certain geographic areas with documented and measurable health disparities. This designation, which expires 10 years after the date on which the first zone is designated, confers eligibility for certain grants, Medicare incentive payments, student loan repayment programs, and tax credits for those working to reduce health disparities and improve health outcomes in these zones. Specifically, community-based nonprofits or local government agencies, in coalition with health care providers, social service organizations, and others, may apply to the Department of Health and Human Services (HHS) for the designation. The application must include a plan to reduce health disparities and achieve other outcomes. In implementing the program, HHS must consult with, among others, the Department of Housing and Urban Development. When approving applications, HHS shall consider factors including geographic diversity and the commitment of supporting funds from the private sector. HHS (1) may award grants to organizations or agencies that applied for the designation to support activities aligned with their plans, and (2) must carry out a student loan repayment program for health care providers who agree to provide services in a Health Enterprise Zone. In addition, the bill establishes tax credits for employers that hire, and individuals who work as, Health Enterprise Zone workers.
Bill· SS. 5295 (117th)referred
United States · United States Congress · 19 December 2022
Comprehensive Cancer Survivorship Act This bill establishes programs and requirements to support the provision of services for cancer survivors, including Medicare coverage of cancer care planning and coordination services, grant programs for navigation services for cancer survivors, and a model to provide cancer survivorship care planning for children under Medicaid and the Children's Health Insurance Program (CHIP).
Bill· SS. 5266 (117th)referred
United States · United States Congress · 15 December 2022
Investing in Infant and Early Childhood Mental Health Act This bill reauthorizes through FY2027 activities that support infant and early childhood mental health promotion, intervention, and treatment programs. It also authorizes the Department of Health and Human Services to provide, directly or through grants or contacts with nonprofits, training and technical assistance related to such programs.
Bill· SS. 5276 (117th)referred
United States · United States Congress · 15 December 2022
Right to Build Families Act of 2022 This bill prohibits states from prohibiting (or unreasonably limiting) access to, provision of, or insurance coverage for assisted reproductive technology (e.g., in vitro fertilization). The Department of Justice and individuals adversely affected by violations may bring a lawsuit to enforce this bill, and states are not immune from suits for violations.
Bill· SS. 5284 (117th)referred
United States · United States Congress · 15 December 2022
Maternal Health Pandemic Response Act of 2022 This bill addresses data collection, public education, workplace safety, and other matters related to maternal health during public health emergencies. Specifically, the bill supports (1) the collection of maternal data (including racial, ethnic, and other demographic data) through surveillance systems of the Centers for Disease Control and Prevention (CDC), and (2) research activities of the National Institute of Child Health and Human Development. Additionally, the CDC and the Centers for Medicare & Medicaid Services must make publicly available and periodically update pregnancy and postpartum data that is collected across COVID-19 surveillance systems. The data must be disaggregated by factors such as race, ethnicity, insurance status, and location. The bill also requires the CDC to educate pregnant people, their employers, and their health care providers about evidenced-based health information concerning COVID-19 and pregnancy; the Department of Health and Human Services to convene a task force to develop recommendations on the provision of maternity care during the COVID-19 (and future) public health emergencies with a particular focus on communities of color and rural populations; the Occupational Safety and Health Administration to issue an emergency temporary standard to protect employees who are at risk from occupational exposure to COVID-19 that considers the risks and needs of pregnant and postpartum employees; and the Government Accountability Office to report on maternal health and public health preparedness, including prenatal, labor and delivery, and postpartum care during the COVID-19 emergency.
Bill· SS. 5272 (117th)referred
United States · United States Congress · 15 December 2022
Increasing Mental Health Options Act of 2022 This bill provides for an additional payment for clinical psychologists under Medicare who provide services in designated health professional shortage areas. It also allows clinical psychologists to provide behavioral health services (in accordance with state law) for purposes of hospitalization services, home health services, and other services under Medicare.
Bill· SS. 5268 (117th)referred
United States · United States Congress · 15 December 2022
NIH Clinical Trial Diversity Act of 2022 This bill sets out requirements to increase the diversity of clinical trial participants. The bill also requires other activities to foster participation in clinical trials. As a condition of funding from the National Institutes of Health (NIH) for a clinical trial investigating a drug or device, a sponsor's application must include certain information related to diversity in its trial, such as goals for recruiting and retaining trial participants and plans for achieving the recruitment and retention goals and implementing less-burdensome clinical trial follow-up requirements. A sponsor must also annually share demographic data of clinical trial participants with the NIH. Further, the NIH and the Food and Drug Administration must carry out a national campaign to increase awareness about the need for diverse clinical trials.
Bill· SS. 5285 (117th)referred
United States · United States Congress · 15 December 2022
Improving Treatment for Pregnant and Postpartum Women Act 2.0 This bill makes permanent a grant program that supports the provision of substance use disorder treatment to pregnant and postpartum women.
Bill· HRH.R. 9571 (117th)referred
United States · United States Congress · 15 December 2022
This bill extends certain liability protections available for health care practitioners who provide voluntary health care services in declared emergencies through a community health center other than the one that initially sponsored them. Current law makes the liability protections available to volunteer practitioners that are sponsored by a particular community health center. This bill maintains the liability protections for a volunteer practitioner who provides services through a different community health center if the center (1) seeks the assistance of the volunteer practitioner to respond to a declared emergency, and (2) promptly notifies the Department of Health and Human Services that the volunteer practitioner will be providing services.
Bill· HRH.R. 9602 (117th)referred
United States · United States Congress · 15 December 2022
Maternal Health Pandemic Response Act of 2022 This bill addresses data collection, public education, workplace safety, and other matters related to maternal health during public health emergencies. Specifically, the bill supports (1) the collection of maternal data (including racial, ethnic, and other demographic data) through surveillance systems of the Centers for Disease Control and Prevention (CDC), and (2) research activities of the National Institute of Child Health and Human Development. Additionally, the CDC and the Centers for Medicare & Medicaid Services must make publicly available and periodically update pregnancy and postpartum data that is collected across COVID-19 surveillance systems. The data must be disaggregated by factors such as race, ethnicity, insurance status, and location. The bill also requires the CDC to educate pregnant people, their employers, and their health care providers about evidenced-based health information concerning COVID-19 and pregnancy; the Department of Health and Human Services to convene a task force to develop recommendations on the provision of maternity care during the COVID-19 (and future) public health emergencies with a particular focus on communities of color and rural populations; the Occupational Safety and Health Administration to issue an emergency temporary standard to protect employees who are at risk from occupational exposure to COVID-19 that considers the risks and needs of pregnant and postpartum employees; and the Government Accountability Office to report on maternal health and public health preparedness, including prenatal, labor and delivery, and postpartum care during the COVID-19 emergency.
Bill· HRH.R. 9580 (117th)referred
United States · United States Congress · 15 December 2022
Resilience Investment, Support, and Expansion from Trauma Act or the RISE from Trauma Act This bill establishes and extends various programs to support infants, children, youth, and families who have experienced, or may experience, trauma. Specifically, the bill allows federal agencies to use specified discretionary funds to implement pilot projects to improve outcomes for children experiencing trauma. It also requires the Department of Health and Human Services to provide tool kits and other guidance to train frontline service providers and certain community members about trauma, toxic stress, and resilience. In addition, the Department of Justice (DOJ) must establish a national center to disseminate to law enforcement agencies best practices and other assistance to enhance interactions with infants, children, youth, and families who are exposed to violence and trauma. Furthermore, the bill establishes grants for multi-sector demonstration projects to prevent and mitigate trauma and toxic stress; interventions to improve outcomes for hospital patients who experience drug overdoses, suicide attempts, or violent injury; and clinical training in infant and early childhood mental health. The bill also authorizes DOJ grants to reduce violence and substance use by preventing children's trauma from exposure to violence and substance use. Additionally, it incorporates trauma-informed practices and otherwise addresses trauma in programs for health care professional education, increasing access to health services, and training for educators.
Bill· HRH.R. 9597 (117th)referred
United States · United States Congress · 15 December 2022
Wildlife Disease Surveillance for Pandemic Prevention Act of 2022 This bill establishes programs, grants, and activities to support surveillance of and response to diseases that affect wildlife (i.e., any animal that is not livestock or poultry).
Bill· HRH.R. 9572 (117th)referred
United States · United States Congress · 15 December 2022
Analyzing Kinetic Impact Projectiles Against Americans Act This bill requires a study on injuries caused by kinetic impact projectiles. These include rubber and plastic bullets, bean bag rounds, and other projectiles commonly used for crowd control. The Department of Health and Human Services must, within 30 days, enter an agreement with the National Academies of Sciences, Engineering, and Medicine to conduct the study.
Bill· HRH.R. 9577 (117th)referred
United States · United States Congress · 15 December 2022
Increasing Mental Health Options Act of 2022 This bill provides for an additional payment for clinical psychologists under Medicare who provide services in designated health professional shortage areas. It also allows clinical psychologists to provide behavioral health services (in accordance with state law) for purposes of hospitalization services, home health services, and other services under Medicare.
Bill· HRH.R. 9594 (117th)referred
United States · United States Congress · 15 December 2022
First Responders' Care Expansion Act of 2022 This bill provides for Medicare coverage of first responders between the ages of 57 and 64 who do not otherwise already qualify for Medicare.
Bill· HRH.R. 9584 (117th)referred
United States · United States Congress · 15 December 2022
Accessible Care by Curbing Excessive lawSuitS Act of 2022 or the ACCESS Act of 2022 This bill establishes rules for health care lawsuits where some amount of coverage or care was provided or paid for by a federal program, regardless of the number of other parties to the claim. The bill sets a three-year maximum statute of limitations from the date of the injury, subject to specific exceptions. Further, noneconomic damages (e.g., damages for pain and suffering) are limited to a maximum of $250,000. The bill permits courts to supervise and limit contingent fees paid to attorneys and sets a maximum contingent fee percentage based on a downward sliding scale as a damages increase. The bill permits either party to introduce evidence of collateral source benefits (e.g., workers’ compensation programs, accident insurance coverage, or other future benefit). Statements by a health care provider expressing fault, sympathy, or apology are, however, inadmissible as evidence of liability. Additionally, a plaintiff must give 90 days’ notice to the health care provider before filing a lawsuit. When filing a health care lawsuit, plaintiffs also must simultaneously submit an affidavit in support of the claim from a health care professional who meets the standards for an expert witness that are provided in the bill. This bill generally does not preempt state laws that impose additional limits on health care liability claims.
Bill· HRH.R. 9567 (117th)referred
United States · United States Congress · 15 December 2022
Increasing Access to Dental Insurance Act This bill permits individuals to enroll in a dental benefits plan on a health insurance exchange without also enrolling in a qualified health plan.
Bill· HRH.R. 9546 (117th)referred
United States · United States Congress · 14 December 2022
Connected Maternal Online Monitoring Act or the Connected MOM Act This bill requires the Centers for Medicare & Medicaid Services to report, and provide resources for states, on coverage of remote physiologic devices and related services (e.g., blood glucose monitors) under Medicaid, so as to improve maternal and child health outcomes for pregnant and postpartum women.
Bill· HRH.R. 9565 (117th)referred
United States · United States Congress · 14 December 2022
Comprehensive Cancer Survivorship Act This bill establishes programs and requirements to support the provision of services for cancer survivors, including Medicare coverage of cancer care planning and coordination services, grant programs for navigation services for cancer survivors, and a model to provide cancer survivorship care planning for children under Medicaid and the Children's Health Insurance Program (CHIP).
Bill· HRH.R. 9559 (117th)referred
United States · United States Congress · 14 December 2022
Innovative Technologies Impacted by COVID-19 Act This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.
Bill· SS. 5254 (117th)referred
United States · United States Congress · 14 December 2022
Promoting Physical Activity for Americans Act This bill requires the Department of Health and Human Services (HHS) to continue issuing at least every 10 years physical-activity guidelines based on the most current scientific and medical knowledge. HHS must also publish updated reports that detail evidence-based practices and highlight continuing physical-activity issues between iterations of the guidelines.
Bill· SS. 5249 (117th)referred
United States · United States Congress · 14 December 2022
Preserving Patient Access to Value-Based Care Act This bill extends certain incentive payments for health professionals who participate in eligible alternative payment models under Medicare.
Bill· SS. 5251 (117th)referred
United States · United States Congress · 14 December 2022
Community Mental Wellness and Resilience Act of 2022 This bill requires the Centers for Disease Control and Prevention to award competitive grants to consortia that represent various community entities (e.g., schools, businesses, and health and human services providers) for carrying out community mental wellness and resilience programs that use a public health approach.
Bill· HRH.R. 9510 (117th)referred
United States · United States Congress · 13 December 2022
Stop Anticompetitive Healthcare Act of 2022 This bill provides the Federal Trade Commission with enforcement authority over certain tax-exempt, hospital or cooperative hospital service organizations.
Bill· HRH.R. 9504 (117th)referred
United States · United States Congress · 13 December 2022
Period PROUD (Providing Resources for Our Underserved and Disadvantaged) Act of 2022 This bill provides additional funding through FY2027 for the Social Services Block Grant to support the provision of menstrual products (e.g., menstrual cups and underwear, sanitary napkins, and tampons) to low-income individuals. (This grant is a flexible funding stream used by states and territories to support a wide range of social services.) The bill also exempts the additional funds from sequestration. Sequestration is a process of automatic, across-the-board reductions under which budgetary resources are permanently cancelled to enforce specific budget policy goals.
Bill· HRH.R. 9505 (117th)referred
United States · United States Congress · 13 December 2022
Find It Early Act This bill requires health insurance plans (including public health insurance programs) to cover screenings and diagnostic imaging (with no cost sharing and no limit on frequency) for individuals who are at an increased risk of breast cancer.
Bill· SS. 5248 (117th)referred
United States · United States Congress · 13 December 2022
Mental Health Workforce for Kids Act This bill reauthorizes through FY2027 and makes other changes to a demonstration program that supports integrating primary care and behavioral health care in underserved, community-based settings through the provision of training to health care providers. Specific changes include expanding the types of providers who may receive training through the program and incorporating a particular focus on pediatrics.
Bill· HRH.R. 9499 (117th)referred
United States · United States Congress · 12 December 2022
Certified Community Behavioral Health Clinic Expansion Act of 2022 This bill incorporates psychosocial rehabilitation services into the Section 223 Demonstration Program for Certified Community Behavioral Health Clinics. It also specifies that for purposes of the program, psychiatric rehabilitation services include community-based services and programs that promote community integration and address social needs.
Bill· HRH.R. 9487 (117th)referred
United States · United States Congress · 12 December 2022
Advancing Safe Medications for Moms and Babies Act of 2022 This bill establishes programs and requirements to support the inclusion of pregnant and lactating women in clinical research. For example, the bill requires the Department of Health and Human Services to align the Food and Drug Administration's regulations for human subjects in clinical trials with other departmental regulations for pregnant women in clinical research. The bill also establishes (1) a national online clearinghouse with information about clinical trials that enroll pregnant and lactating women, (2) an advisory committee to help coordinate federal activities with respect to clinical research for pregnant and lactating women, and (3) an educational campaign on the importance of including pregnant and lactating women in clinical research. The National Institutes of Health must also prioritize certain research projects on new and existing medications for pregnant and lactating women based on need, feasibility, and the potential impact of the research.